Sorry, you need to enable JavaScript to visit this website.

This site is intended only for healthcare professionals resident in the United Kingdom

Prescribing information can be found at the bottom of the page

Anidulafungin, an evidence-based treatment for invasive candidiasis, has been used in adult neutropenic patients and patients with deep tissue infection1

Global success at EOIVT in neutropenic patients*

Full preview Global success at EOIVT in neutropenic patients

Resolved neutropenia; ANC>500 cells/mm3 before EOIVT. Persistent neutropenia, ANC≤500 cells/ mm3 at EOIVT.

*Pooled analysis of data from one randomised, double-blind, comparative study and four open-label, non-comparative studies. The neutropenic subset was a limited number of 46 patients at baselines; post-baseline ANC data were available for 26/46 patients.1,2

Adapted from Herbrecht et al 20142

ANC, absolute neutrophil count; EOIVT, end of intravenous therapy

References
    1.     Ecalta® Summary of Product Characteristics.
    2.     Herbrecht R, et al. Abstract R692. Presented at the 24th ECCMID 2014.